Rubella Prevention
Journal: Annals of Internal Medicine (1984)

Diagnosis and Treatment1 October 1984Rubella PreventionRecommendation of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-101-4-505 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractThese revised Immunization Practices Advisory Committee recommendations for the prevention of rubella update the previous recommendations to include current information about vaccine effectiveness, duration of immunity, vaccination in pregnancy, and progress in controlling congenital rubella syndrome. Although there are no basic changes in approach, the available epidemiologic data indicate that the elimination of congenital rubella syndrome can be achieved and even hastened by focusing particular attention on more effective delivery of vaccine to older persons—particularly women of childbearing age. The importance of vaccinating preschool-aged children is also emphasized. As the incidence of rubella declines, serologic confirmation of cases becomes more important. Recommendations for international travel are included.Selected Bibliography1. BABAYABUUCHIOKUNI KHH. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated, and naturally immune groups. Biken J. 1978;21:25-31. MedlineGoogle Scholar2. BALFOURGROTHEDELMANARNRENBESTBANATVALA HKCDJJ. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet. 1981;1:1078-80. CrossrefMedlineGoogle Scholar3. BUIMOVICI-KLEINHITEBRYNECOOPER ERTL. Isolation of rubella virus in milk after postpartum immunization. J Pediatr. 1977;91:939-41. CrossrefMedlineGoogle Scholar4. . Rubella in universities—Washington, California. MMWR. 1982;32:394-5. Google Scholar5. . Rubella outbreak among office workers—New York City. MMWR. 1983;32:349-52. MedlineGoogle Scholar6. . Rubella vaccination during pregnancy—United States, 1971-1982. MMWR. 1983;32:429-432, 437. Google Scholar7. . Rubella and congenital rubella—United States, 1983. MMWR. 1984;33:237-42, 247. MedlineGoogle Scholar8. CHAPPELLTAYLOR JM. Implications of rubella susceptibility in young adults. Am J Pub Health. 1979;69:279-81. CrossrefMedlineGoogle Scholar9. COOPERKRUGMAN LS. The rubella problem. DM. 1969;Feb:3-38. Google Scholar10. COYLEWOLINSKYBUIMOVICI-KLEINMOUCHACOOPER PJERL. Rubella-specific immune complexes after congenital infection and vaccination. Infect Immun. 1982;36:498-503. CrossrefMedlineGoogle Scholar11. CRAWFORDGREMILLION GD. Epidemic measles and rubella in air force recruits: impact of immunization. J Infect Dis. 1981;144:403-10. CrossrefMedlineGoogle Scholar12. DALESCHIN LJ. An outbreak of congenital rubella. West J Med. 1981;135:266-70. MedlineGoogle Scholar13. DALESCHIN LJ. Public health implications of rubella antibody levels in California. Am J Public Health. 1982;72:167-72. CrossrefMedlineGoogle Scholar14. GREAVESORENSTEINHINMANNERSESIAN WWAW. Clinical efficacy of rubella vaccine. Pediatr Infect Dis. 1983;2:284-6. CrossrefMedlineGoogle Scholar15. GREAVESORENSTEINSTETLERPREBLUDHINMANBART WWWSAK. Prevention of rubella transmission in medical facilities. JAMA. 1982;248:861-4. CrossrefMedlineGoogle Scholar16. HERRMANNHALSTEADWIEBENGA KSN. Rubella antibody persistence after immunization. JAMA 1982;247:193-6. CrossrefMedlineGoogle Scholar17. HILLARYGRIFFITH IA. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine. Br Med J. 1980;280:1580-1. CrossrefMedlineGoogle Scholar18. HORSTMANN D. Controlling rubella: problems and perspectives. Ann Intern Med. 1975;83:412-7. LinkGoogle Scholar19. International conference on rubella immunization. Am J Dis Child. 1969;118:1-410. Google Scholar20. International Symposium on the Prevention of Congenital Rubella Infection, Washington, D.C., March 13-15, 1984. Rev Infect Dis. (In press). Google Scholar21. KLEINBYRNECOOPER ETL. Neonatal rubella in a breast-fed infant after postpartum maternal infection. J Pediatr. 1980;97:774-5. CrossrefMedlineGoogle Scholar22. LANDESBASSMILLUNCHICKOETGEN RJEW. Neonatal rubella following postpartum maternal immunization. J Pediatr. 1980;97:465-7. CrossrefMedlineGoogle Scholar23. KOPLANWHITE JC. An update of the benefits and costs of measles and rubella immunization. In: Proceedings of the Symposium "Conquest of Agents that Endanger the Brain," Baltimore, Maryland, October 28-29, 1982. (In press). Google Scholar24. LANDRIGANSTOFFELSANDERSONWITTE PMEJ. Epidemic rubella in adolescent boys: clinical features and results of vaccination. JAMA. 1974;227:1283-7. CrossrefMedlineGoogle Scholar25. LAMPRECHTSCHAUFWARRENNELSONNORTHROPCHRISTIANSEN CVDKRM. An outbreak of congenital rubella in Chicago. JAMA. 1982;247:1129-33. CrossrefMedlineGoogle Scholar26. LERMANNANKERVISHEGGIEGOLD SGAE. Immunologic response, virus excretion, and joint reactions with rubella vaccine: a study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5). Ann Intern Med. 1971;74:67-73. LinkGoogle Scholar27. LIEBERMANFAICHSIMONMULLAN EGPR. Premarital rubella screening in Rhode Island. JAMA. 1981;245:1333-5. CrossrefMedlineGoogle Scholar28. MANNPREBLUDHOFFMANBRANDLING-BENNETHINMANHERRMANN JSRAAK. Assessing risks of rubella infection during pregnancy: a standardized approach. JAMA. 1981;245:1647-52. CrossrefMedlineGoogle Scholar29. MCLAUGHLINGOLD ML. The New York rubella incident: a case for changing hospital policy regarding rubella testing and immunization. Am J Public Health. 1979;69:287-9. CrossrefMedlineGoogle Scholar30. MILLERCRADOCK-WATSONPOLLOCK EJT. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781-4. CrossrefMedlineGoogle Scholar31. MILLERZAGER KT. Rubella susceptibility in an adolescent female population. Mayo Clin Proc. 1984;59:31-4. CrossrefMedlineGoogle Scholar32. NELSONLAYDECHATTON DMT. Rubella susceptibility in inner-city adolescents: the effect of a school immunization law. Am J Public Health. 1982;72:710-3. CrossrefMedlineGoogle Scholar33. ORENSTEINBARTHINMAN WKA. The opportunity and obligation to eliminate rubella from the United States. JAMA. 1984;251:1988-94. CrossrefMedlineGoogle Scholar34. O'SHEABESTBANATVALA SJJ. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis. 1983;148:639-47. CrossrefMedlineGoogle Scholar35. O'SHEABESTBANATVALAMARSHALLDUDGEON SJJWJ. Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J 1982;285:253-5. CrossrefMedlineGoogle Scholar36. POLKMODLINWHITEDEGIROLAMI BJJP. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am J Epidemiol. 1982;115:19-25. CrossrefMedlineGoogle Scholar37. POLKWHITEDEGIROLAMIMODLIN BJPJ. An outbreak of rubella among hospital personnel. N Engl J Med. 1980;303:541-5. CrossrefMedlineGoogle Scholar38. PREBLUDGROSSHALSEYHINMANHERRMANNKOPLAN SFNAKJ. Assessment of susceptibility to measles and rubella. JAMA. 1982;247:1134-7. CrossrefMedlineGoogle Scholar39. PREBLUDSERDULAFRANKBRANDLING-BENNETTHINMAN SMJAA. Rubella vaccination in the United States: a ten-year review. Epidemiol Rev. 1980;2:171-94. CrossrefMedlineGoogle Scholar40. PREBLUDSTETLERFRANKGREAVESHINMANHERRMANN SHJWAK. Fetal risk associated with rubella vaccine. JAMA. 1981;246:1413-7. CrossrefMedlineGoogle Scholar41. . Recommendations for the control of rubella within hospitals. Infect Control. 1981;2:410-1,424. CrossrefMedlineGoogle Scholar42. ROBINSONDUDENHOEFFERHOLROYDBAKERBERNSTEINCHERRY RFHLDJ. Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized. J Pediatr 1982;101:188-91. CrossrefMedlineGoogle Scholar43. SERDULAHALSTEADWIEBENGAHERRMANN MSNK. Serological response to rubella revaccination. JAMA. 1984;251:1974-7. CrossrefMedlineGoogle Scholar44. STORCHMYERS GN. Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. J Infect Dis. 1984;149:459-64. CrossrefMedlineGoogle Scholar45. TINGLEYANGALLENKETTYLSLARKESCHULZER ATMGRM. Prospective immunological assessment of arthritis induced by rubella vaccine. Infect Immun. 1983;40:22-8. CrossrefMedlineGoogle Scholar46. WEIBELBUYNAKMCLEANROEHMHILLEMANN REARM. Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med. 1980;165:260-3. CrossrefMedlineGoogle Scholar47. WEIBELVILLAREJOSKLEINBUYNAKMCLEANHILLEMAN RVEEAM. Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines (40931). Proc Soc Exp Biol Med. 1980;165:44-9. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: ▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byGeneral Pediatric TherapyChildhood Exanthems: Old and NewRoutine immunization of the HIV-positive asymptomatic patientDevelopment of automated immunoassays for immune status screening and serodiagnosis of rubella virus infectionInfection Control Considerations for In Vitro Fertilization and Embryo Transfer ProgramsImmunizing the adultEvaluation of a rapid passive hemagglutination assay for anti-rubella antibody: Comparison to hemagglutination inhibition and a vaccine challenge study 1 October 1984Volume 101, Issue 4Page: 505-513KeywordsChildrenEpidemiologyImmunityPregnancyRubellaVaccines ePublished: 1 December 2008 Issue Published: 1 October 1984 PDF downloadLoading ...